Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Good efficacy and safety profile described for ranibizumab in AMD

Sep. 3, 2003

Intravitreous hyaluronidase effective in reducing vitreous hemorrhage density

Sep. 3, 2003

VEGF Trap prevents blinding blood vessel growth in mice

Aug. 28, 2003

Improved vision in extension phase of Lucentis wet AMD study

Aug. 27, 2003

Priority review for Vitrase NDA

Aug. 25, 2003

Long-term efficacy of Retaane demonstrated in 24-month wet AMD trial

Aug. 25, 2003

New phase III trial of loteprednol etabonate for allergic rhinitis

Aug. 21, 2003

Selective iNOS inhibitors show potential in the treatment of endotoxin-induced uveitis

Aug. 21, 2003

Phase IIIb results support use of diquafosol in dry eye

Aug. 20, 2003

AlphaCor introduction for cornea transplant patients who reject human tissue

Aug. 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...